Free Trial

Rep. Bruce Westerman Sells Danaher Co. (NYSE:DHR) Stock

Danaher logo with Medical background

Representative Bruce Westerman (R-Arkansas) recently sold shares of Danaher Co. NYSE: DHR. In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Danaher stock on April 21st. The trade occurred in the Representative's "FISHER IRA" account.

Representative Bruce Westerman also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of UniCredit OTCMKTS: UNCRY on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of CSX NASDAQ: CSX on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Siemens Aktiengesellschaft OTCMKTS: SIEGY on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of GSK NYSE: GSK on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Abbott Laboratories NYSE: ABT on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 4/21/2025.
  • Sold $15,001 - $50,000 in shares of NVIDIA NASDAQ: NVDA on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Chevron NYSE: CVX on 4/21/2025.

Danaher Stock Up 0.1%

DHR stock traded up $0.22 during mid-day trading on Monday, hitting $196.33. 2,724,501 shares of the company were exchanged, compared to its average volume of 3,451,188. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The firm has a market cap of $140.51 billion, a P/E ratio of 37.18, a P/E/G ratio of 2.66 and a beta of 0.80. The firm's 50 day simple moving average is $196.69 and its 200 day simple moving average is $216.91. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. On average, sell-side analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher's dividend payout ratio (DPR) is currently 24.85%.

Insider Activity

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman now owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. This represents a 51.01% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Royal Bank of Canada reiterated an "outperform" rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, April 23rd. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. UBS Group lowered their price objective on shares of Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Robert W. Baird lowered their price objective on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Citigroup reiterated a "buy" rating on shares of Danaher in a report on Monday, April 7th. Four analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $264.40.

Check Out Our Latest Research Report on Danaher

Hedge Funds Weigh In On Danaher

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DHR. Norges Bank bought a new position in Danaher during the fourth quarter worth $2,130,740,000. Nuveen LLC bought a new position in Danaher during the first quarter worth $833,941,000. GAMMA Investing LLC boosted its position in Danaher by 24,958.2% during the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock worth $383,524,000 after purchasing an additional 1,863,381 shares during the period. Raymond James Financial Inc. bought a new position in Danaher during the fourth quarter worth $391,172,000. Finally, Two Sigma Advisers LP boosted its position in Danaher by 4,248.8% during the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after purchasing an additional 1,601,800 shares during the period. 79.05% of the stock is owned by institutional investors.

About Representative Westerman

Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas' 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027. Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas' 4th Congressional District. He declared candidacy for the 2026 election. Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.

Danaher Company Profile

(Get Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines